China National MedicinesSHSE:600511 +1.62%86 EV-to-FCF is 62.07 as of Jul. 04, 2026, which is 360% above its 10-year median of 13.48. GuruFocus rates SHSE:600511 with a GF Score™ of 86/100 and a GF Value™ of ¥32.74 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 75 Medical Distribution companies, China National Medicines ranks worse than 82.67% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, China National Medicines's Enterprise Value is ¥14,803 Mil.
China National Medicines's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥238 Mil. Therefore, China National Medicines's EV-to-FCF for today is 62.07.
The historical rank and industry rank for China National Medicines's EV-to-FCF or its related term are showing as below:
SHSE:600511'
s EV-to-FCF Range Over the Past 10 Years
Min: -19865.69 Med: 13.48 Max: 69.19
Current: 62.07
During the past 13 years, the highest EV-to-FCF of China National Medicines was 69.19. The lowest was -19865.69. And the median was 13.48.
SHSE:600511's EV-to-FCF is ranked worse than 82.67% of 75
companies
in the Medical Distribution industry
Industry Median: 16.66
vs SHSE:600511: 62.07
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China National Medicines (SHSE:600511) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
China National Medicines's PE Ratio (TTM) for today is calculated as:
China National Medicines's share price for today is ¥26.94.
China National Medicines's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.667.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
China National Medicines EV-to-FCF Related Terms
China National Medicines EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600511 vs MCK, CAH, COR: EV-to-FCF Comparison
For the Medical Distribution subindustry, China National Medicines's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China National Medicines EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China National Medicines's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where China National Medicines's EV-to-FCF falls into.
China National Medicines's current Enterprise Value is ¥14,803 Mil.
China National Medicines's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥238 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China National Medicines (SHSE:600511) has a EV-to-FCF of 62.07 as of Jul. 04, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China National Medicines and its competitors. This is 360% above median its historical median of 13.48. According to the industry distribution chart, China National Medicines ranks #62 out of 75 companies in the Medical Distribution industry, placing it in the top 82.7%.
Is China National Medicines' EV-to-FCF too high?
China National Medicines' current EV-to-FCF of 62.07 is 360% above median its 10-year median of 13.48. The Medical Distribution industry median EV-to-FCF is 16.66. China National Medicines' value of 62.07 is 272.6% above this industry median. Based on the distribution chart, China National Medicines ranks #62 out of 75 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, China National Medicines has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China National Medicines' EV-to-FCF compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, China National Medicines ranks #62 out of 75 companies for EV-to-FCF. This places China National Medicines in the lower half of its industry. The industry median EV-to-FCF is 16.66. China National Medicines' value of 62.07 is 272.6% above this benchmark. While the company's 10-year median is 13.48 vs. the industry median of 16.66, China National Medicines has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 16.66, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China National Medicines's current EV-to-FCF of 62.07 is 272.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on China National Medicines and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 16.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China National Medicines's current EV-to-FCF is 62.07, which is 360% above median its own 10-year median of 13.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China National Medicines stock overvalued right now?
Based on GuruFocus' analysis, China National Medicines (SHSE:600511) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥32.74, compared to a current price of ¥26.94 — trading 17.7% below its estimated fair value. The current EV-to-FCF is 62.07, which is 360% above median its 10-year median of 13.48 and 272.6% above the Medical Distribution industry median of 16.66. China National Medicines' overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For China National Medicines (SHSE:600511), the current EV-to-FCF is 62.07 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China National Medicines (SHSE:600511) Overvalued in 2026?
Based on GuruFocus' analysis, China National Medicines stock appears to be undervalued.
The current stock price of ¥26.94 is trading 17.7% below its estimated GF Value™ of ¥32.74.
GuruFocus considers China National Medicines to be Modestly Undervalued.
Key valuation signals for SHSE:600511:
EV-to-FCF: 62.07 (360% above median its 10-year median of 13.48)
GF Value™: ¥32.74 vs. price of ¥26.94 (17.7% below fair value)
Industry Position: 272.6% above the Medical Distribution median (#62 of 75)
No single metric tells the full story. See the SHSE:600511 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company conducts its operations through two primary segments. The Commercial segment is mainly engaged in the sale of pharmaceuticals. The Others segment focuses on pharmaceutical manufacturing and logistics operations.
86GF Score
Get the complete analysis for SHSE:600511
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600511 has been successfully added to your 
